{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:44:02Z","timestamp":1779342242281,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.vaccine.2011.01.007","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T09:31:03Z","timestamp":1295515863000},"page":"2066-2070","source":"Crossref","is-referenced-by-count":36,"title":["Guillain\u2013Barr\u00e9 syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition"],"prefix":"10.1016","volume":"29","author":[{"given":"Young June","family":"Choe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeyeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geun-Ryang","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Koo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.01.007_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1982.03330060038030","article-title":"Guillain\u2013Barre syndrome in the United States, 1979\u20131980 and 1980\u20131981, Lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0015","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a115973","article-title":"Reassessment of the association between Guillain\u2013Barre syndrome and receipt of swine influenza vaccine in 1976\u20131977: results of a two-state study, Expert Neurology Group","volume":"133","author":"Safranek","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0020","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain\u2013Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0025","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1016\/j.vaccine.2010.05.031","article-title":"The 2009 A (H1N1) influenza virus pandemic: a review","volume":"28","author":"Girard","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0030","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1016\/j.vaccine.2010.07.010","article-title":"Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience","volume":"28","author":"Sander","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0035","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.vaccine.2008.11.035","article-title":"Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems","volume":"27","author":"Bonhoeffer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0040","first-page":"657","article-title":"Preliminary results: surveillance for Guillain\u2013Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine\u2014United States, 2009\u20132010","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0264-410X(02)00449-8","article-title":"The Brighton siva: addressing the need for standardized case definitions of adverse events following immunization (AEFI)","volume":"21","author":"Bonhoeffer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0050","article-title":"Guillain\u2013Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","author":"Sejvar","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3201\/eid0601.000103","article-title":"Japanese encephalitis immunization in South Korea: past, present, and future","volume":"6","author":"Sohn","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0060","first-page":"121","article-title":"National vaccine injury compensation program in Korea: a 12-year experience","author":"Kim","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0065","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","volume":"7","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0070","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amepre.2010.05.022","article-title":"Evaluation of Guillain\u2013Barre Syndrome among recipients of influenza vaccine in 2000 and 2001","volume":"39","author":"Burwen","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0075","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","article-title":"The Guillain\u2013Barre syndrome","volume":"326","author":"Ropper","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0080","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain\u2013Barre syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0090","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1086\/650530","article-title":"Guillain\u2013Barre syndrome in children aged <15 years in Latin America and the Caribbean: baseline rates in the context of the influenza A (H1N1) pandemic","volume":"201","author":"Landaverde","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1590\/S0004-282X2002000300005","article-title":"Guillain\u2013Barre syndrome in a population less than 15 years old in Brazil","volume":"60","author":"Dias-Tosta","year":"2002","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0100","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0105","first-page":"265","article-title":"Monitoring vaccine safety during an influenza pandemic","volume":"78","author":"Iskander","year":"2005","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14760584.7.1.75","article-title":"Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience","volume":"7","author":"Iskander","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0115","first-page":"205","article-title":"Does informing patients of the risk of acquiring Guillain\u2013Barre syndrome following influenza vaccination have an effect on their willingness to be vaccinated?","volume":"26","author":"De Wals","year":"2000","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2010.09.021","article-title":"Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the vaccine adverse events reporting system, United States, October 1, 2009\u2013January 31, 2010","author":"Vellozzi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0125","first-page":"1351","article-title":"Safety of influenza A (H1N1) 2009 monovalent vaccines\u2014United States, October 1\u2013November 24, 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.01.007_bib0130","doi-asserted-by":"crossref","first-page":"A91","DOI":"10.1016\/j.vaccine.2010.02.040","article-title":"Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices","volume":"28","author":"Cho","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0135","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association of Guillain\u2013Barre syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.01.007_bib0140","doi-asserted-by":"crossref","DOI":"10.1177\/0883073810370481","article-title":"A clinical picture of Guillain\u2013Barre syndrome in children in the United States","author":"Hicks","year":"2010","journal-title":"J Child Neurol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T23:25:28Z","timestamp":1740871528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0264410X11000235"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}